Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Samsara BioCapital GP, LLC — Scholar Rock Holding Corp insider: 1 transactions · InsiderLens

Home / Insiders / Samsara BioCapital GP, LLC

Samsara BioCapital GP, LLC

10% owner at Scholar Rock Holding Corp · on record since Jun 21, 2023
10% owner at CARGO Therapeutics, Inc. · on record since Nov 16, 2023
10% owner at vTv Therapeutics Inc. · on record since Feb 29, 2024
10% owner at Mineralys Therapeutics, Inc. · on record since Feb 14, 2024
10% owner at Kalaris Therapeutics, Inc. · on record since May 22, 2026
10% owner at Neurogene Inc. · on record since Nov 27, 2024

Insider trading activity of Samsara BioCapital GP, LLC

Transactions on record: 1; since Oct 18, 2023

Open-market buys: 1; $15M

Open-market sells: 0

Companies traded: 1; last filing Oct 18, 2023

Figures computed from official regulatory filings — methodology.

Companies where Samsara BioCapital GP, LLC has traded

Scholar Rock Holding Corp1 tx · $15M · Oct 18, 2023

Track record of Samsara BioCapital GP, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Samsara BioCapital GP, LLC

Co-insiders of Samsara BioCapital GP, LLC

AKKARAJU SRINIVASCARGO Therapeutics, Inc. +5
Samsara BioCapital, L.P.CARGO Therapeutics, Inc. +5
667, L.P.Neurogene Inc. +1
Baker Bros. Advisors (GP) LLCNeurogene Inc. +1
BAKER BROS. ADVISORS LPNeurogene Inc. +1
Baker Brothers Life Sciences LPNeurogene Inc. +1
BAKER FELIXNeurogene Inc. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BAKER JULIANNeurogene Inc. +1

Hallal DavidKalaris Therapeutics, Inc. +1

Sinha VikasKalaris Therapeutics, Inc. +1

Woods KeithNeurogene Inc. +1

Abrams Robin ElizabethvTv Therapeutics Inc.

ADAMIS ANTHONY PKalaris Therapeutics, Inc.

Adams Derek N.Kalaris Therapeutics, Inc.

Alam KamranNeurogene Inc.

Al-Marzooqi FahedvTv Therapeutics Inc.

Al-Nahyan Tahnoon Bin Zayed S.vTv Therapeutics Inc.

ALTSTIEL LARRY DOUGLASvTv Therapeutics Inc.

ARCH Venture Fund VIII, L.P.Scholar Rock Holding Corp

ARCH Venture Partners VIII, LLCScholar Rock Holding Corp

ARCH Venture Partners VIII, L.P.Scholar Rock Holding Corp

ARTAL GROUP S AScholar Rock Holding Corp

Artal International Management S.A.Scholar Rock Holding Corp

ARTAL INTERNATIONAL SCAScholar Rock Holding Corp

Asam AlexanderMineralys Therapeutics, Inc.

Atillasoy ErcemKalaris Therapeutics, Inc.

Backstrom Jay T.Scholar Rock Holding Corp

BAFFI ROBERTNeurogene Inc.

Bassan AbrahamCARGO Therapeutics, Inc.

Bornstein Jeffrey SKalaris Therapeutics, Inc.

Brainard DianaKalaris Therapeutics, Inc.

Brenner MalcolmKalaris Therapeutics, Inc.

Bridger GaryNeurogene Inc.

Brown Barry K.vTv Therapeutics Inc.

Brudnick RichardScholar Rock Holding Corp

BUCKLER ALAN J.Scholar Rock Holding Corp

Burow KristinaScholar Rock Holding Corp

BYBEE CLINTONScholar Rock Holding Corp

Carven Gregory JohnScholar Rock Holding Corp

Catalys Pacific Fund, LPMineralys Therapeutics, Inc.

Chapman GinaCARGO Therapeutics, Inc.

Cheong RaymondvTv Therapeutics Inc.

CHICKO RHONDA M.Scholar Rock Holding Corp

CHYUNG YUNG H.Scholar Rock Holding Corp

Cobb StuartNeurogene Inc.

Cohen Steven MichaelvTv Therapeutics Inc.

Congleton JonMineralys Therapeutics, Inc.

CRANDELL KEITHScholar Rock Holding Corp

Cvijic Christine MikailNeurogene Inc.

DEBBANE RAYMONDScholar Rock Holding Corp

Company	Filed	Type	Qty	Price	Value · USD	Src
Scholar Rock Holding Corp	Oct 18, 2023	Buy	2,189,781	6.85 USD	$15M	SEC